The mis-regulation of signaling pathways in Alzheimer’s disease have serious impact on amyloid-β secretion, Tau phosphorylation, neurotransmitter signaling, glial function which eventually ameliorate the disease condition. This evidence concerns the gene MAPT and Alzheimer disease.